35
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21616 |
L-006235
L 006235 |
Cysteine Protease | Proteases/Proteasome |
L-006235 是一种口服有活性的、可逆的cathepsin K 选择性抑制剂,在骨吸收试验中的IC50值为 5 nM。它能够抑制胶原蛋白降解,并较少骨质流失。 | |||
T27730 |
KGP94
KGP-94,KGP 94 |
Cysteine Protease | Proteases/Proteasome |
KGP94 是一种有效的、选择性的和竞争性的溶酶体内肽酶抑制剂。 | |||
T38469 |
(Rac)-Z-Phe-Phe-FMK
Cathepsin L-IN-2 |
Beta Amyloid; Cysteine Protease | Neuroscience; Proteases/Proteasome |
(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) 是一种 cathepsin L 抑制剂,抑制 β-淀粉样蛋白诱导凋亡变化的倾向 。(Rac)-Z-Phe-Phe-FMK 通过 siRNA 敲低 LC3B 表达可抑制 PI 诱导的 IkappaBalpha 降解。 | |||
T72569 |
Cathepsin L/S-IN-1
|
||
CathepsinL/S-IN-1 是 Cathepsin L 和 Cathepsin S 的双重抑制剂,IC50分别为 4.10 μM 和 1.79 μM。CathepsinL/S-IN-1 对胰腺癌 BxPC-3 和 PANC-1 细胞具有显著的抗转移和侵袭作用。 | |||
T6015 |
Cathepsin Inhibitor 1
|
Cysteine Protease | Proteases/Proteasome |
Cathepsin inhibitor 1 是Cathepsin 的选择性抑制剂,能够抑制CatL(pIC50:7.9)、CatL2(pIC50:6.7)、CatS(pIC50:6.0)、CatK(pIC50:5.5)和CatB(pIC50:5.2)。 | |||
T12909 |
SID 26681509
|
Cysteine Protease; Parasite | Microbiology/Virology; Proteases/Proteasome |
SID 26681509 是可逆的,竞争性的人组织蛋白酶 L 选择性抑制剂,IC50为 56 nM。它抑制Plasmodium falciparum 的体外繁殖,IC50为15.4 μM,抑制Leishmania major,IC5012.5 μM。 | |||
T13288 |
VBY-825
|
Cysteine Protease | Proteases/Proteasome |
VBY-825是cathepsin 一种新型的可逆抑制剂,对cathepsin B, L, S 和V 都有很高的抑制力。 | |||
T16089 |
MK-0674
|
Cysteine Protease | Proteases/Proteasome |
MK-0674 是一种可口服且具有选择性和高效性的 cathepsin K 抑制剂(IC50:0.4 nM),抑制 Cat B、Cat F、Cat L 和 Cat S,可用于和代谢相关的疾病。 | |||
T37504L |
Cathepsin D and E FRET Substrate acetate(839730-93-7 Free base)
Cathepsin D and E FRET Substrate acetate(839730-93-7 Free base) |
||
Cathepsin D and E FRET Substrate acetate 是组织蛋白酶 D 和 E 的荧光底物,但不适用于 B、H 或 L。Cathepsin D and E FRET Substrate acetate 可用于组织蛋白酶 D 和 E 研究的机理研究。 | |||
TP2056L |
Acetyl-Calpastatin (184-210)(human) acetate
Acetyl-Calpastatin (184-210) (human) acetate(123714-50-1 Free base ) |
Cysteine Protease | Proteases/Proteasome |
Acetyl-Calpastatin (184-210)(human) acetate 是一种有效,选择性和可逆的钙蛋白酶 (calpain) 抑制剂,对 μ-钙蛋白酶和组织蛋白酶 L 的 Ki 值分别为 0.2 nM 和 6 μM。 | |||
T1850 |
Balicatib
AAE581,巴利卡替 |
Cysteine Protease | Proteases/Proteasome |
Balicatib (AAE581) 是组织蛋白酶K 抑制剂,其对组织蛋白酶K 的抑制作用是组织蛋白酶B、L 和S 的抑制性的10到100倍。 | |||
T15641 |
K777
APC-3316 |
P450; Cysteine Protease; CCR | Immunology/Inflammation; Metabolism; Microbiology/Virology; Proteases/Proteasome |
K777 是有效的,具有口服活性的,不可逆的半胱氨酸蛋白酶 (cysteine protease) 抑制剂。K777是有效的 CYP3A4 抑制剂(IC50= 60 nM)。K777也是选择性的 CCR4 拮抗剂,显示出强的趋化性抑制作用。K777 对 Cruzain(克鲁斯锥虫的主要半胱氨酸蛋白酶)和组织蛋白酶 B 和 L 具有不可逆的抑制作用。K777 通过靶向组织蛋白酶介导的细胞进入,显示出广谱的抗病毒作用。K777 抑制 EBOV 和 SARS-CoV 病毒的进入,IC50 值分别为 0.87 nM 和 0.68 nM。 | |||
T35753 |
Z-Phe-Tyr(tBu)-diazomethylketone
|
||
Irreversible cathepsin L inhibitor which is ca 10'000 times more effective in inactivating cathepsin L than cathepsin S. | |||
T16092 |
L-873724
|
Others | Others |
L-873724 inhibits bone resorption. L-873724 is an effective, selective, and reversible non-basic cathepsin K inhibitor (IC50s: 0.2, 178, 264, and 5239 nM for cathepsin K, cathepsin S, cathepsin L, cathepsin B, respectively). L-873724 also shows an IC50 of | |||
T80105 |
Z-Phe-Phe-Diazomethylketone
|
||
Z-Phe-Phe-Diazomethylketone 为cathepsin L 特异性抑制剂。 | |||
T71275 | CID16725315 | ||
Thiocarbazate, also known as CID16725315, is an inhibitor of human cathepsin L. Inhibition of cathepsin L thus holds promise for therapeutic intervention for both SARS-CoV and Ebola virus infection. With respect to the development of antiviral agents, inhibitors of human cathepsin L are not subject to resistance because of rapid mutations of the viral genome. Cathepsin L is therefore an attractive target for drug development. | |||
T26938 |
CAA0225
CAA 0225,CAA-0225 |
||
CAA0225 is a selective inhibitor of cathepsin L. CAA0225 is a probe for autophagic proteolysis. | |||
T80739 |
Z-FG-NHO-BzOME
|
||
Z-FG-NHO-BzOME 是一种选择性半胱氨酸蛋白酶抑制剂,主要作用于组织蛋白酶 B、组织蛋白酶 L、组织蛋白酶 S 及木瓜蛋白酶。 | |||
T37053 |
Z-(L-Arg)-AMC (hydrochloride)
|
||
Z-(L-Arg)-AMC is a fluorogenic substrate for trypsin, cathepsin B, and cathepsin H.1,2Upon enzymatic cleavage by trypsin, cathepsin B, or cathepsin H, 7-amino-4-methylcoumarin (AMC) is released and its fluorescence can be used to quantify trypsin, cathepsin B, and cathepsin H activity. AMC displays excitation/emission maxima of 340-360/440-460 nm, respectively. 1.Zimmerman, M., Ashe, B., Yurewicz, E.C., et al.Sensitive assays for trypsin, elastase, and chymotrypsin using new fluorogenic substrat... | |||
T71618 | Oxocarbazate | ||
Oxocarbazate, also known as CID23631927, is an inhibitor of human cathepsin L. In the cathepsin L inhibition assay, The oxocarbazate caused a time-dependent 17-fold drop in IC50 from 6.9 nM (no preincubation) to 0.4 nM (4-h preincubation). Slowly reversible inhibition was demonstrated in a dilution assay. CID23631927 demonstrate activity in blocking both SARS-CoV (IC50 = 273 nM) and Ebola virus (IC50 = 193 nM) entry into human embryonic. CID 23631927 was a subnanomolar, slow-binding, reversible... | |||
T81265 |
RKLLW-NH2
|
||
RKLLW-NH2为一种组织蛋白酶L抑制剂。 | |||
T78186 |
Ac-VLPE-FMK
Ac-Val-Leu-Pro-Glu(OMe)-CH2F |
||
Ac-VLPE-FMK为一种四肽基单氟甲基酮(m-FMK),兼作Cat-B及Cat-L抑制剂,适用于癌症侵袭性研究。 | |||
T41236 |
Z-FY-CHO
|
||
Z-FY-CHO (Z-Phe-Tyr-CHO) 是一种特异且有效的组织蛋白酶 L (CTSL) 抑制剂。 | |||
T40463 |
Relacatib
SB-462795 |
||
Relacatib (SB-462795) is a novel, potent, and orally active inhibitor of human cathepsins K, L, and V. It exhibits high affinity for these enzymes, with Ki values of 41 pM, 68 pM, and 53 pM, respectively. Moreover, Relacatib effectively inhibits endogenous cathepsin K in situ in human osteoclasts, as well as human osteoclast-mediated bone resorption, with IC 50 values of 45 nM and 70 nM, respectively. Additionally, in vitro studies demonstrate Relacatib's inhibitory effect on bone resorption in ... | |||
T36942 |
SSAA09E1
SSAA09E1 |
||
SSAA09E1 is an inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV) viral entry.1It reduces infection of HEK293T cells transiently transfected with angiotensin-converting enzyme 2 (ACE2) by an HIV-based virus system pseudotyped with SARS-CoV surface glycoprotein (EC50= 6.7 μM). SSAA09E1 also inhibits the proteolytic activity of cathepsin L (IC50= 5.33 μM) but not cathepsin B when used at a concentration of 20 μM. 1.() | |||
T73554 | SPR38 | ||
SPR38 是一种有效的 SARS-CoV-2 主要蛋白酶 (SARS-CoV-2 main protease) 抑制剂,Ki 为 0.260 μM。SPR38 还抑制hCatL 和hCatB,Ki 值分别为 1.92 μM 和 11.1 μM。 | |||
T73553 |
SPR39
|
||
SPR39 是一种有效的 SARS-CoV-2 主要蛋白酶抑制剂,对 SARS-CoV-2 Mpro, hCatL, hCatB 的 Ki 值分别为 0.252、3.38、7.88 µM。SPR39 具有抗病毒和细胞毒性。 | |||
T63831 | SID 26681509 quarterhydrate | ||
SID 26681509 quarterhydrate 是可逆的、有效的、选择性的、竞争性的人组织蛋白酶 L (human cathepsin L) 抑制剂 (IC50: 56 nM)。SID 26681509 quarterhydrate 能够抑制Plasmodium falciparum 的体外繁殖 (IC50: 15.4 μM),并抑制Leishmania major (IC50: 12.5 μM),且不抑制组织蛋白酶 G 的活性。 | |||
TP2056 |
Acetyl-Calpastatin(184-210)(human)
Acetyl-Calpastatin (184-210) (human) |
||
Selective calpain inhibitor. Strongly inhibits calpain I (Ki = 0.2 nM) and II but does not inhibit papain, trypsin and cathepsin L (Ki = 6 μM). Increases secretion of amyoid β-protein (Aβ) 42, Aβ40 and Aβ42 ratio. | |||
T73395 | ASPER-29 | ||
ASPER-29是一种Asperphenamate类似物,对组织蛋白酶L和S均显示出双重抑制作用,其IC50值分别为6.03 μM和5.02 μM。此化合物主要应用于癌症迁移和侵袭的研究。 | |||
T62494 | Cathepsin C-IN-5 | ||
CathepsinC-IN-5 (compound SF38) 为一高效、选择性、口服活性的组织蛋白酶 C (Cat C) 抑制剂,其针对Cat C、Cat L、Cat S、Cat B、Cat K 的IC50s 分别为 59.9 nM、4.26 µM、>5 µM、>5 µM、>5 µM。该化合物能够抑制骨髓和血液中的Cat C活性,降低中性粒细胞丝氨酸蛋白酶(NSP)的激活,并展现抗炎活性。 | |||
T75794 |
Acetyl-Calpastatin(184-210)(human) TFA
|
||
Acetyl-Calpastatin(184-210)(human) TFA 是一种有效,选择性和可逆的钙蛋白酶 (calpain) 抑制剂,对 μ-钙蛋白酶和组织蛋白酶 L 的Ki 值分别为 0.2 nM 和 6 μM。 | |||
T11864 |
Iptacopan
LNP023 |
Others | Others |
Iptacopan (LNP023) 是一种与factor B 亲和力较高的抑制剂。 | |||
T72446 |
SARS-CoV-2 Mpro-IN-4
|
||
SARS-CoV-2 Mpro-IN-4是针对主要蛋白酶(MPro)和组织蛋白酶L(CatL)的双重抑制剂,其IC50s分别为900 nM和60 nM。此化合物对SARS-CoV2展现出抗病毒活性,在hACE2表达的A549细胞中可有效阻断SARS-CoV2复制,其IC50值为8.2 nM。 | |||
T72447 |
SARS-CoV-2 Mpro-IN-5
|
||
SARS-CoV-2 Mpro-IN-5是一种针对主要蛋白酶(MPro)和组织蛋白酶L(CatL)的双重抑制剂,具备IC50s分别为1800 nM和145 nM。该化合物在对抗SARS-CoV2方面显示出显著的抗病毒活性,并能在表达hACE2的A549细胞中阻断SARS-CoV2复制,IC50值达14.7 nM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TJS2216 |
Aurantiamide acetate
金色酰胺醇酯,Asperglaucide |
Cysteine Protease | Proteases/Proteasome |
Aurantiamide acetate (Asperglaucide) 是抑制口服有活性的 cathepsin 选择性抑制剂,分离自 Portulaca oleracea L。它具有抗炎作用,可用于研究炎性相关疾病。 | |||
T6564 |
Leupeptin Hemisulfate
亮肽素 |
Serine Protease; Cysteine Protease | Proteases/Proteasome |
Leupeptin hemisulfate 是一种蛋白酶抑制剂,具有细胞膜渗透性、可逆性、竞争性和口服活性。Leupeptin hemisulfate 可以抑制 Cathepsin B、Cathepsin H、Cathepsin L 的活性,阻断两性溶酶体的融合。Leupeptin hemisulfate 还具有抗炎活性。 | |||
TN1249 |
3-Epiursolic acid
|
Cysteine Protease; Immunology/Inflammation related | Immunology/Inflammation; Proteases/Proteasome |
3-Epiursolic Acid 是一种三萜类物质,分离自桃金娘科植物,是组织蛋白酶 L 的竞争性抑制剂(IC50=6.5 μM,Ki=19.5 μM),对 cathepsin B 无明显作用。 | |||
T19392 |
L-Homocysteine
|
Others | Others |
L-Homocysteine, an L-configured homocysteine metabolite, induces the upregulation of cathepsin V, which mediates vascular endothelial inflammation in hyperhomocysteinaemia. | |||
T72898 |
Gallinamide A
|
||
Gallinamide A 是一种组织蛋白酶 L 的有效抑制剂,其 IC50值为 17.6 pM。 |